This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Tuesday's Early Winners & Losers

Kronos (KRON) jumped more than 8% in after-hours action Monday after the business-software company widened its fiscal first-quarter profits. Excluding items, the Chelmsford, Mass., company earned $11.5 million, or 36 cents a share, in the quarter ended Dec. 30, compared with $11 million, or 34 cents a share, a year ago.

Analysts polled by Thomson Financial were looking for 33 cents. Revenue was up 16% to $148.7 million, which squeaks past the consensus. Shares were rising $2.79 to $36.79 in recent trading.

Angeion (ANGN), which makes cardio-respiratory diagnostic systems, swung to a full-year profit and more than doubled its earnings for the fiscal fourth quarter. The St. Paul, Minn., small-cap said it made $1.4 million in the year ended Oct. 31, or 40 cents a share, compared with last year's loss of $919,000, or 25 cents a share.

Income for the quarter came to $755,000, or 21 cents a share, on revenue that surged 60.9% from a year ago to $10.7 million. Shares were gaining $1.37, or 8.6%, to $17.40.

Threshold Pharma (THLD - Get Report) was higher after the Redwood City, Calif.-based company said it's starting patient enrollment for phase II testing on glufosfamide as a treatment for platinum-resistant ovarian cancer -- a condition that Threshold says constitutes almost half of all diagnosed ovarian cancer cases. Shares were up 19 cents, or 5.4%, to $3.70.

CNet (CNET - Get Report) rose on better-than-expected fourth-quarter results. The tech Web site operator's non-GAAP income fell 2 cents a share to $19.6 million, or 13 cents a share, but analysts had sought a penny less. Sales grew 14% to $118.4 million and beat the $111.8 million estimate.

For the quarter already in progress, the San Francisco-based company is expecting a bottom line between a loss of 2 cents and break-even a share on sales of between $90 million and $94 million. Analysts are looking for a 3-cent-per-share loss, on $91.8 million in revenue. Shares were adding 38 cents, or 4.5%, to $8.78.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
INNO $0.02 0.00%
CNET $1.63 0.00%
PCL $43.23 0.00%
THLD $4.57 0.00%
AAPL $129.36 0.00%

Markets

DOW 18,203.37 -85.26 -0.47%
S&P 500 2,107.78 -9.61 -0.45%
NASDAQ 4,979.9010 -28.1950 -0.56%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs